These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1385 related items for PubMed ID: 8784084

  • 21. Evaluation of serum basal thyrotrophin levels and thyrotrophin receptor antibody activities as prognostic markers for discontinuation of antithyroid drug treatment in patients with Graves' disease.
    Cho BY, Shong MH, Yi KH, Lee HK, Koh CS, Min HK.
    Clin Endocrinol (Oxf); 1992 Jun; 36(6):585-90. PubMed ID: 1358483
    [Abstract] [Full Text] [Related]

  • 22. Thyroidal response to an increase or decrease of endogenous TSH in patients with hyperthyroidism and its correlation with TSH binding inhibiting immunoglobulin.
    Katakura M, Koizumi Y, Aizawa T, Takasu N, Yamada T, Yukimura Y, Nagata H.
    Clin Exp Pharmacol Physiol; 1986 May; 13(5):407-15. PubMed ID: 2874908
    [Abstract] [Full Text] [Related]

  • 23. [Effect of thyroxine upon prevention of recurrence of Graves' disease treated with antithyroid drugs].
    Wu G, Jie Y, Situ Y.
    Zhonghua Yi Xue Za Zhi; 2001 Mar 10; 81(5):274-5. PubMed ID: 11798886
    [Abstract] [Full Text] [Related]

  • 24. Relationship between CTLA-4 and CD28 molecule expression on T lymphocytes and stimulating and blocking autoantibodies to the TSH-receptor in children with Graves' disease.
    Bossowski A, Stasiak-Barmuta A, Urban M.
    Horm Res; 2005 Mar 10; 64(4):189-97. PubMed ID: 16220002
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Association of thyrotrophin receptor antibodies with the clinical features of Graves' ophthalmopathy.
    Gerding MN, van der Meer JW, Broenink M, Bakker O, Wiersinga WM, Prummel MF.
    Clin Endocrinol (Oxf); 2000 Mar 10; 52(3):267-71. PubMed ID: 10718823
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Preserved activation of thyrotropin receptor antibody to stimulate thyroid function despite long-term treatment in euthyroid patients with Graves' disease.
    Akuzawa M, Murakami M, Yamada M, Satoh T, Shimizu H, Mori M.
    Eur J Endocrinol; 1998 Mar 10; 138(3):281-5. PubMed ID: 9539302
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Predicting a relapse of Graves' hyperthyroidism in adults during the early phase of treatment with anti-thyroid drugs.
    Jonas M, Ambroziak U, Bednarczuk T, Nauman J.
    Endokrynol Pol; 2006 Mar 10; 57(6):596-604. PubMed ID: 17253432
    [Abstract] [Full Text] [Related]

  • 32. Reappraisal of the 3,5,3'-triiodothyronine-suppression test in the prediction of long term outcome of antithyroid drug therapy in patients with hyperthyroid Graves' disease.
    Yamada T, Koizumi Y, Sato A, Hashizume K, Aizawa T, Takasu N, Nagata H.
    J Clin Endocrinol Metab; 1984 Apr 10; 58(4):676-80. PubMed ID: 6421866
    [Abstract] [Full Text] [Related]

  • 33. [Fluctuations in the titers of anti-thyroid hormone and anti-thyroglobulin antibodies in 4 cases of Graves' disease during long-term treatment period].
    Komaki T, Sakata S, Nakamura S, Matsuda M, Kojima N, Takuno H, Miura K.
    Nihon Naibunpi Gakkai Zasshi; 1989 Jul 20; 65(7):627-39. PubMed ID: 2583311
    [Abstract] [Full Text] [Related]

  • 34. Medical therapy of Graves' disease: does thyroxine prevent recurrence of hyperthyroidism?
    Lucas A, Salinas I, Rius F, Pizarro E, Granada ML, Foz M, Sanmartí A.
    J Clin Endocrinol Metab; 1997 Aug 20; 82(8):2410-3. PubMed ID: 9253309
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Development of primary hypothyroidism with the appearance of blocking-type antibody to thyrotropin receptor in Graves' disease in late pregnancy.
    Ueta Y, Fukui H, Murakami H, Yamanouchi Y, Yamamoto R, Murao A, Santou Y, Taniguchi S, Mitani Y, Shigemasa C.
    Thyroid; 1999 Feb 20; 9(2):179-82. PubMed ID: 10090319
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 70.